微芯生物: 股票异常波动公告

Core Viewpoint - Shenzhen Micu Biotechnology Co., Ltd. experienced a significant stock price fluctuation, with a cumulative increase of 30% over three consecutive trading days from July 1 to July 3, 2025, which is classified as abnormal trading activity according to relevant regulations [1][2]. Group 1: Stock Trading Abnormalities - The company's stock price increased by 30% over three trading days, indicating abnormal trading activity as per the Shanghai Stock Exchange rules [1]. - The company conducted a self-examination and confirmed that there are no undisclosed significant information affecting the stock price, including mergers, debt restructuring, or asset transfers [2]. Group 2: Company Operations and Market Conditions - The company reported that its production and operational activities are normal, with no significant changes in market conditions or industry policies [2]. - There have been no major fluctuations in production costs or sales, and the internal operational order remains stable [2]. Group 3: Board of Directors' Statement - The Board of Directors confirmed that there are no undisclosed matters that should be reported according to the Shanghai Stock Exchange rules, and they have not been made aware of any significant information that could impact the stock price [2].